Methodology

All entries for: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

February 11, 2026

Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Orphan Drug Designation

treatment of pancreatic cancer

Disease Area: Rare Disease
Source
Source
Scroll to Top